Specialty Pharmacy

Sun Pharma launches Cequa

Cequa is the first and only FDA approved cyclosporine treatment delivered with nanomicellar, or NCELL technology.

Akorn gets FDA nod for betamethasone dipropionate

Betamethasone dipropionate lotion (augmented), 0.05% had a market value of approximately $10 million for the 12 months ended August 2019, according to IQVIA.

Diplomat taps David Skomo as CastiaRx COO

Following the retirement of Chris Luthin, David Skomo has been named COO of Diplomat's pharmacy benefit manager CastiaRx.

AmerisourceBergen selected by Karyopharm to support Xpovio

AmerisourceBergen has been chosen by Karyopharm to introduce a new treatment for patients with relapsed or refractory multiple myeloma.

Amber Pharmacy to dispense Celgene's Inrebic

Amber Pharmacy will dispense Celgene's Inrebic, a treatment for patients with certain types of myelofibrosis.

PDX introduces Envoy Dx

PDX is releasing Envoy Dx to meet the needs and custom data feeds required in specialty pharmacy reporting.

AllianceRx Walgreens Prime expands specialty drugs for rare conditions

AllianceRx Walgreens Prime has added new specialty drugs for patients with rare conditions, such as MS and non-Hodgkin's lymphoma.

GSK taps EMD Serono’s Martinez-Davis as U.S. pharmaceuticals president

Maya Martinez-Davis will assume the role as GSK president of U.S. pharmaceuticals, succeeding Jack Bailey, who will remain as a strategic consultant to GSK through 2020.

Diplomat posts Q2 loss along with drop in PBM, specialty revenue

Alongside its earnings, Diplomat Pharmacy announced that it is reviewing strategic alternatives, including a sale or merger, as well as pursuing value-enhancing initiatives as a standalone company.